ORIGINAL RESEARCH
Toxicological Assessment of Aluminum Sulfate
and Three Mitochondrial Respiratory
Chain Inhibitors (Trimetazidine, Prednisolone,
and Potassium cyanide) on Yeast
Saccharomyces Cerevisiae
More details
Hide details
1
Laboratory of Cell Toxicology, Department of Biology, Faculty of Sciences, University of Annaba
2
Environmental Research Center, University of Annaba
3
Toxicology and ecosystems pathologies Laboratory, Larbi Tebessi university, Algeria
Submission date: 2024-04-19
Final revision date: 2024-05-25
Acceptance date: 2024-06-28
Online publication date: 2024-09-10
Corresponding author
Rachid Rouabhi
Toxicology and ecosystems pathologies Laboratory, Larbi Tebessi university, Algeria
KEYWORDS
TOPICS
ABSTRACT
Aluminum (Al) is a widely found metal with no known biological or clinical benefits, and thus
causes considerable toxicological effects on biological organisms’ health, including yeast.
Mitochondria are the main cellular organelles involved in the production of oxygen and reactive oxygen
species (ROS) in the cell. Yeast is the most scientifically used micro-ecologic, and the most sensitive
microorganisms to various toxicants. As the toxicological effects of Al and mitochondrial respiratory
chain inhibitors on Saccharomyces cerevisiae have not been elucidated; the present study
was therefore, devoted to comparing the toxic effects of Al salts and three mitochondrial inhibitors,
namely trimetazidine, Prednisolone, and Potassium Cyanide on Saccharomyces cerevisiae. Cells were
exposed 2h increasing concentrations of Al (C1 = 0.017g/L, C2 = 0.034g/L, C3 = 0.342 g/L,
and C4 = 8,5 g/L), and one concentration of mitochondrial inhibitor C1 = 0.0032g/L Potassium Cyanide
(KCN), C1 = 0.013 g/L Trimetazidine (TMZ), and C1 = 0.018 g/L Prednisolone (PDN). Results showed
an inhibition of cell growth in Al2 (SO4)3 and the used mitochondrial inhibitors, in particular, Cyanide
and Prednisolone as evidenced by positive response percentages in exposed yeasts. Moreover, oxidative
stress induction in Aluminum sulfate treatment was revealed by stimulation of catalase (CAT)
and Glutathione S-transferase (GST) activity, along with increased levels of GSH and MDA compared
with control.